HealthRegulation
FDA Panel Backs Broader Access to Gray Market Peptides
FDA panel voted to ease restrictions on six peptides, allowing compounding pharmacies to produce them and potentially curbing the unregulated gray market.
—5 min read
Tag
3 articles
FDA panel voted to ease restrictions on six peptides, allowing compounding pharmacies to produce them and potentially curbing the unregulated gray market.
Belgium's donor scandal expands as egg donors exceed the legal limit of six families, revealing systemic failures in fertility treatment oversight.
A De Morgen investigation exposes gaps in Belgium's supplement regulation, sparking debate over enforcement, influencer marketing, and consumer protection.